Erythema multiforme (EM) is a rare skin condition that is characterized by an itchy rash that appears on the skin in the form of red patches, bumps, or blisters. It is usually caused by an allergic reaction to a medication or infection, but can also be caused by an autoimmune disorder. The condition can be mild or severe, and it can affect people of any age. While the rash can be painful and uncomfortable, it is usually not serious and can be treated with over-the-counter medications or topical creams. In this article, we will provide a visual guide to erythema multiforme, including what it looks like, the symptoms associated with it, and the treatment options available.
Erythema multiforme typically appears as red patches, bumps, or blisters on the skin. The rash can appear anywhere on the body, but is most commonly found on the hands, feet, and face. The rash can range in size from a few millimeters to several centimeters in diameter. It is usually symmetrical, meaning that it appears on both sides of the body. The rash is usually itchy and can be painful or tender to the touch. The rash can also have a “target” or “bull’s-eye” appearance, with a central red area surrounded by a ring of paler red. This is known as the “iris” pattern and is a characteristic of erythema multiforme. In some cases, the rash may also have a purplish or bluish hue.
In addition to the rash, erythema multiforme can also cause other symptoms, including fever, chills, sore throat, and fatigue. In some cases, the rash may be accompanied by eye irritation, such as redness, swelling, and pain. It is important to note that erythema multiforme is not contagious and cannot be spread from person to person.
Erythema multiforme is usually caused by an allergic reaction to a medication or infection. Common triggers include antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs), and anticonvulsants. In some cases, the condition can be caused by an autoimmune disorder, such as lupus or Sjogren’s syndrome.
Erythema multiforme is usually diagnosed based on the appearance of the rash. Your doctor may also take a skin sample (biopsy) to confirm the diagnosis. In some cases, blood tests may be used to rule out other conditions that may be causing the rash.
The treatment of erythema multiforme depends on the severity of the condition. Mild cases may be treated with over-the-counter medications, such as antihistamines, or topical creams. In more severe cases, your doctor may prescribe oral steroids or other medications to reduce inflammation and itching.
Erythema multiforme is a rare skin condition that is characterized by an itchy rash that appears on the skin in the form of red patches, bumps, or blisters. It is usually caused by an allergic reaction to a medication or infection, but can also be caused by an autoimmune disorder. While the rash can be painful and uncomfortable, it is usually not serious and can be treated with over-the-counter medications or topical creams. This article provided a visual guide to erythema multiforme, including what it looks like, the symptoms associated with it, and the treatment options available.
1.
Advances in "next generation" photoactive cancer therapy
2.
Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL
3.
The American College of Physicians updated its recommendations for colorectal cancer screening.
4.
Optimizing Sequencing of BCMA-Directed Therapies in Myeloma
5.
According to a study, patients with ovarian cancer who undergo aggressive surgery have a 70% lower chance of dying.
1.
Quality of Life Using Precision Functional Recovery After Organ-Preserving Interventions
2.
Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis
3.
Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy
4.
Modern Developments in Oncology for Specialists
5.
Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
2.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
3.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
4.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
5.
Navigating the Complexities of Ph Negative ALL - Part XII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation